nodes	percent_of_prediction	percent_of_DWPC	metapath
Lercanidipine—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.17	0.254	CbGbCtD
Lercanidipine—CYP3A7—Ifosfamide—germ cell cancer	0.17	0.254	CbGbCtD
Lercanidipine—CYP3A5—Ifosfamide—germ cell cancer	0.128	0.19	CbGbCtD
Lercanidipine—CYP3A5—Etoposide—germ cell cancer	0.0611	0.091	CbGbCtD
Lercanidipine—CYP3A4—Ifosfamide—germ cell cancer	0.0498	0.0742	CbGbCtD
Lercanidipine—CYP2D6—Vinblastine—germ cell cancer	0.0416	0.0619	CbGbCtD
Lercanidipine—CYP3A4—Vinblastine—germ cell cancer	0.0264	0.0394	CbGbCtD
Lercanidipine—CYP3A4—Etoposide—germ cell cancer	0.0238	0.0355	CbGbCtD
Lercanidipine—CACNA1D—cochlea—germ cell cancer	0.0097	0.186	CbGeAlD
Lercanidipine—CACNA1D—internal ear—germ cell cancer	0.0092	0.176	CbGeAlD
Lercanidipine—CACNA1D—ear—germ cell cancer	0.0062	0.119	CbGeAlD
Lercanidipine—CYP3A4—urine—germ cell cancer	0.00193	0.037	CbGeAlD
Lercanidipine—CYP2D6—urine—germ cell cancer	0.0019	0.0364	CbGeAlD
Lercanidipine—CACNA1D—telencephalon—germ cell cancer	0.00149	0.0285	CbGeAlD
Lercanidipine—CACNA1C—telencephalon—germ cell cancer	0.00137	0.0263	CbGeAlD
Lercanidipine—CACNA1C—decidua—germ cell cancer	0.0013	0.0249	CbGeAlD
Lercanidipine—CACNA1D—pituitary gland—germ cell cancer	0.00121	0.0232	CbGeAlD
Lercanidipine—CYP3A7—endocrine gland—germ cell cancer	0.00121	0.0232	CbGeAlD
Lercanidipine—CACNA1C—pituitary gland—germ cell cancer	0.00112	0.0214	CbGeAlD
Lercanidipine—CACNA1D—adrenal gland—germ cell cancer	0.00108	0.0207	CbGeAlD
Lercanidipine—CACNA1C—adrenal gland—germ cell cancer	0.000998	0.0191	CbGeAlD
Lercanidipine—CACNA1D—endocrine gland—germ cell cancer	0.000937	0.018	CbGeAlD
Lercanidipine—CACNA1D—head—germ cell cancer	0.000925	0.0177	CbGeAlD
Lercanidipine—CACNA1D—testis—germ cell cancer	0.000894	0.0171	CbGeAlD
Lercanidipine—CACNA1C—endocrine gland—germ cell cancer	0.000865	0.0166	CbGeAlD
Lercanidipine—CACNA1C—head—germ cell cancer	0.000854	0.0164	CbGeAlD
Lercanidipine—CACNA1D—cerebellum—germ cell cancer	0.000826	0.0158	CbGeAlD
Lercanidipine—CACNA1C—testis—germ cell cancer	0.000825	0.0158	CbGeAlD
Lercanidipine—CACNA1C—cerebellum—germ cell cancer	0.000762	0.0146	CbGeAlD
Lercanidipine—CACNA1D—brain—germ cell cancer	0.000671	0.0129	CbGeAlD
Lercanidipine—CACNA1D—lymph node—germ cell cancer	0.000648	0.0124	CbGeAlD
Lercanidipine—Feeling abnormal—Vinblastine—germ cell cancer	0.000625	0.00226	CcSEcCtD
Lercanidipine—Myalgia—Dactinomycin—germ cell cancer	0.000623	0.00225	CcSEcCtD
Lercanidipine—Ill-defined disorder—Ifosfamide—germ cell cancer	0.000622	0.00225	CcSEcCtD
Lercanidipine—Eye disorder—Cisplatin—germ cell cancer	0.000621	0.00224	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00062	0.00224	CcSEcCtD
Lercanidipine—Anaemia—Ifosfamide—germ cell cancer	0.00062	0.00224	CcSEcCtD
Lercanidipine—Tinnitus—Cisplatin—germ cell cancer	0.000619	0.00224	CcSEcCtD
Lercanidipine—CACNA1C—brain—germ cell cancer	0.000619	0.0119	CbGeAlD
Lercanidipine—Lymphadenopathy—Methotrexate—germ cell cancer	0.000617	0.00223	CcSEcCtD
Lercanidipine—Flushing—Cisplatin—germ cell cancer	0.000616	0.00223	CcSEcCtD
Lercanidipine—Cardiac disorder—Cisplatin—germ cell cancer	0.000616	0.00223	CcSEcCtD
Lercanidipine—Discomfort—Dactinomycin—germ cell cancer	0.000615	0.00222	CcSEcCtD
Lercanidipine—Angioedema—Ifosfamide—germ cell cancer	0.000613	0.00221	CcSEcCtD
Lercanidipine—Anorexia—Bleomycin—germ cell cancer	0.00061	0.00221	CcSEcCtD
Lercanidipine—Diabetes mellitus—Methotrexate—germ cell cancer	0.000606	0.00219	CcSEcCtD
Lercanidipine—Malaise—Ifosfamide—germ cell cancer	0.000605	0.00219	CcSEcCtD
Lercanidipine—Vertigo—Ifosfamide—germ cell cancer	0.000602	0.00218	CcSEcCtD
Lercanidipine—Urinary tract disorder—Etoposide—germ cell cancer	0.000601	0.00217	CcSEcCtD
Lercanidipine—Polyuria—Methotrexate—germ cell cancer	0.0006	0.00217	CcSEcCtD
Lercanidipine—Photosensitivity—Methotrexate—germ cell cancer	0.0006	0.00217	CcSEcCtD
Lercanidipine—Immune system disorder—Cisplatin—germ cell cancer	0.0006	0.00217	CcSEcCtD
Lercanidipine—Abdominal pain—Vinblastine—germ cell cancer	0.000599	0.00217	CcSEcCtD
Lercanidipine—Mediastinal disorder—Cisplatin—germ cell cancer	0.000598	0.00216	CcSEcCtD
Lercanidipine—Hypotension—Bleomycin—germ cell cancer	0.000598	0.00216	CcSEcCtD
Lercanidipine—CACNA1C—lymph node—germ cell cancer	0.000598	0.0115	CbGeAlD
Lercanidipine—Urethral disorder—Etoposide—germ cell cancer	0.000596	0.00215	CcSEcCtD
Lercanidipine—Palpitations—Ifosfamide—germ cell cancer	0.000593	0.00214	CcSEcCtD
Lercanidipine—Alopecia—Cisplatin—germ cell cancer	0.000587	0.00212	CcSEcCtD
Lercanidipine—Hepatic failure—Methotrexate—germ cell cancer	0.000586	0.00212	CcSEcCtD
Lercanidipine—Cough—Ifosfamide—germ cell cancer	0.000585	0.00211	CcSEcCtD
Lercanidipine—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000585	0.00211	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000583	0.00211	CcSEcCtD
Lercanidipine—Erythema—Cisplatin—germ cell cancer	0.000578	0.00209	CcSEcCtD
Lercanidipine—Malnutrition—Cisplatin—germ cell cancer	0.000578	0.00209	CcSEcCtD
Lercanidipine—Erythema multiforme—Etoposide—germ cell cancer	0.000575	0.00208	CcSEcCtD
Lercanidipine—Paraesthesia—Bleomycin—germ cell cancer	0.000575	0.00208	CcSEcCtD
Lercanidipine—Dyspnoea—Bleomycin—germ cell cancer	0.000571	0.00206	CcSEcCtD
Lercanidipine—Arthralgia—Ifosfamide—germ cell cancer	0.000571	0.00206	CcSEcCtD
Lercanidipine—Myalgia—Ifosfamide—germ cell cancer	0.000571	0.00206	CcSEcCtD
Lercanidipine—Chest pain—Ifosfamide—germ cell cancer	0.000571	0.00206	CcSEcCtD
Lercanidipine—Anorexia—Dactinomycin—germ cell cancer	0.000569	0.00206	CcSEcCtD
Lercanidipine—Eye disorder—Etoposide—germ cell cancer	0.000569	0.00205	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000567	0.00205	CcSEcCtD
Lercanidipine—Cardiac disorder—Etoposide—germ cell cancer	0.000565	0.00204	CcSEcCtD
Lercanidipine—Flushing—Etoposide—germ cell cancer	0.000565	0.00204	CcSEcCtD
Lercanidipine—Discomfort—Ifosfamide—germ cell cancer	0.000564	0.00204	CcSEcCtD
Lercanidipine—CYP2D6—brainstem—germ cell cancer	0.000562	0.0108	CbGeAlD
Lercanidipine—Hypersensitivity—Vinblastine—germ cell cancer	0.000559	0.00202	CcSEcCtD
Lercanidipine—Dermatitis exfoliative—Methotrexate—germ cell cancer	0.000558	0.00202	CcSEcCtD
Lercanidipine—Decreased appetite—Bleomycin—germ cell cancer	0.000557	0.00201	CcSEcCtD
Lercanidipine—Muscle spasms—Cisplatin—germ cell cancer	0.000556	0.00201	CcSEcCtD
Lercanidipine—Angiopathy—Etoposide—germ cell cancer	0.000552	0.00199	CcSEcCtD
Lercanidipine—Confusional state—Ifosfamide—germ cell cancer	0.000552	0.00199	CcSEcCtD
Lercanidipine—Immune system disorder—Etoposide—germ cell cancer	0.000549	0.00199	CcSEcCtD
Lercanidipine—Mediastinal disorder—Etoposide—germ cell cancer	0.000548	0.00198	CcSEcCtD
Lercanidipine—Vision blurred—Cisplatin—germ cell cancer	0.000545	0.00197	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.000544	0.00197	CcSEcCtD
Lercanidipine—Asthenia—Vinblastine—germ cell cancer	0.000544	0.00197	CcSEcCtD
Lercanidipine—Alopecia—Etoposide—germ cell cancer	0.000538	0.00194	CcSEcCtD
Lercanidipine—Cerebrovascular accident—Methotrexate—germ cell cancer	0.000538	0.00194	CcSEcCtD
Lercanidipine—Nervous system disorder—Ifosfamide—germ cell cancer	0.000537	0.00194	CcSEcCtD
Lercanidipine—Ill-defined disorder—Cisplatin—germ cell cancer	0.000536	0.00194	CcSEcCtD
Lercanidipine—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000536	0.00194	CcSEcCtD
Lercanidipine—Anaemia—Cisplatin—germ cell cancer	0.000534	0.00193	CcSEcCtD
Lercanidipine—Skin disorder—Ifosfamide—germ cell cancer	0.000532	0.00192	CcSEcCtD
Lercanidipine—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000529	0.00191	CcSEcCtD
Lercanidipine—Feeling abnormal—Bleomycin—germ cell cancer	0.000528	0.00191	CcSEcCtD
Lercanidipine—Anorexia—Ifosfamide—germ cell cancer	0.000522	0.00188	CcSEcCtD
Lercanidipine—Malaise—Cisplatin—germ cell cancer	0.000521	0.00188	CcSEcCtD
Lercanidipine—Decreased appetite—Dactinomycin—germ cell cancer	0.000519	0.00188	CcSEcCtD
Lercanidipine—Diarrhoea—Vinblastine—germ cell cancer	0.000519	0.00187	CcSEcCtD
Lercanidipine—Dysgeusia—Etoposide—germ cell cancer	0.000519	0.00187	CcSEcCtD
Lercanidipine—Fatigue—Dactinomycin—germ cell cancer	0.000515	0.00186	CcSEcCtD
Lercanidipine—Hypotension—Ifosfamide—germ cell cancer	0.000511	0.00185	CcSEcCtD
Lercanidipine—Muscle spasms—Etoposide—germ cell cancer	0.000509	0.00184	CcSEcCtD
Lercanidipine—Urticaria—Bleomycin—germ cell cancer	0.000509	0.00184	CcSEcCtD
Lercanidipine—Body temperature increased—Bleomycin—germ cell cancer	0.000506	0.00183	CcSEcCtD
Lercanidipine—Dizziness—Vinblastine—germ cell cancer	0.000501	0.00181	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000499	0.0018	CcSEcCtD
Lercanidipine—CYP2D6—telencephalon—germ cell cancer	0.000499	0.00956	CbGeAlD
Lercanidipine—Myalgia—Cisplatin—germ cell cancer	0.000492	0.00178	CcSEcCtD
Lercanidipine—Feeling abnormal—Dactinomycin—germ cell cancer	0.000492	0.00178	CcSEcCtD
Lercanidipine—Paraesthesia—Ifosfamide—germ cell cancer	0.000491	0.00178	CcSEcCtD
Lercanidipine—Ill-defined disorder—Etoposide—germ cell cancer	0.000491	0.00178	CcSEcCtD
Lercanidipine—Anxiety—Cisplatin—germ cell cancer	0.00049	0.00177	CcSEcCtD
Lercanidipine—Anaemia—Etoposide—germ cell cancer	0.000489	0.00177	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000489	0.00177	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000488	0.00176	CcSEcCtD
Lercanidipine—Dyspnoea—Ifosfamide—germ cell cancer	0.000488	0.00176	CcSEcCtD
Lercanidipine—Somnolence—Ifosfamide—germ cell cancer	0.000486	0.00176	CcSEcCtD
Lercanidipine—Discomfort—Cisplatin—germ cell cancer	0.000486	0.00176	CcSEcCtD
Lercanidipine—Vomiting—Vinblastine—germ cell cancer	0.000482	0.00174	CcSEcCtD
Lercanidipine—Malaise—Etoposide—germ cell cancer	0.000478	0.00173	CcSEcCtD
Lercanidipine—Breast disorder—Methotrexate—germ cell cancer	0.000476	0.00172	CcSEcCtD
Lercanidipine—Vertigo—Etoposide—germ cell cancer	0.000476	0.00172	CcSEcCtD
Lercanidipine—Decreased appetite—Ifosfamide—germ cell cancer	0.000476	0.00172	CcSEcCtD
Lercanidipine—Headache—Vinblastine—germ cell cancer	0.000475	0.00172	CcSEcCtD
Lercanidipine—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000474	0.00171	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000472	0.00171	CcSEcCtD
Lercanidipine—Body temperature increased—Dactinomycin—germ cell cancer	0.000472	0.00171	CcSEcCtD
Lercanidipine—Abdominal pain—Dactinomycin—germ cell cancer	0.000472	0.00171	CcSEcCtD
Lercanidipine—Fatigue—Ifosfamide—germ cell cancer	0.000472	0.0017	CcSEcCtD
Lercanidipine—Hypersensitivity—Bleomycin—germ cell cancer	0.000472	0.0017	CcSEcCtD
Lercanidipine—Constipation—Ifosfamide—germ cell cancer	0.000468	0.00169	CcSEcCtD
Lercanidipine—Loss of consciousness—Etoposide—germ cell cancer	0.000465	0.00168	CcSEcCtD
Lercanidipine—Nervous system disorder—Cisplatin—germ cell cancer	0.000463	0.00167	CcSEcCtD
Lercanidipine—Cough—Etoposide—germ cell cancer	0.000462	0.00167	CcSEcCtD
Lercanidipine—Thrombocytopenia—Cisplatin—germ cell cancer	0.000462	0.00167	CcSEcCtD
Lercanidipine—Tachycardia—Cisplatin—germ cell cancer	0.00046	0.00166	CcSEcCtD
Lercanidipine—Asthenia—Bleomycin—germ cell cancer	0.000459	0.00166	CcSEcCtD
Lercanidipine—Skin disorder—Cisplatin—germ cell cancer	0.000458	0.00166	CcSEcCtD
Lercanidipine—CYP3A5—female gonad—germ cell cancer	0.000458	0.00878	CbGeAlD
Lercanidipine—Hyperhidrosis—Cisplatin—germ cell cancer	0.000456	0.00165	CcSEcCtD
Lercanidipine—Asthma—Methotrexate—germ cell cancer	0.000455	0.00165	CcSEcCtD
Lercanidipine—Pruritus—Bleomycin—germ cell cancer	0.000453	0.00164	CcSEcCtD
Lercanidipine—Feeling abnormal—Ifosfamide—germ cell cancer	0.000451	0.00163	CcSEcCtD
Lercanidipine—Chest pain—Etoposide—germ cell cancer	0.000451	0.00163	CcSEcCtD
Lercanidipine—Nausea—Vinblastine—germ cell cancer	0.00045	0.00163	CcSEcCtD
Lercanidipine—Anorexia—Cisplatin—germ cell cancer	0.00045	0.00163	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000448	0.00162	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000447	0.00162	CcSEcCtD
Lercanidipine—Pancreatitis—Methotrexate—germ cell cancer	0.000446	0.00161	CcSEcCtD
Lercanidipine—Discomfort—Etoposide—germ cell cancer	0.000445	0.00161	CcSEcCtD
Lercanidipine—Hypotension—Cisplatin—germ cell cancer	0.000441	0.00159	CcSEcCtD
Lercanidipine—Hypersensitivity—Dactinomycin—germ cell cancer	0.00044	0.00159	CcSEcCtD
Lercanidipine—Confusional state—Etoposide—germ cell cancer	0.000436	0.00157	CcSEcCtD
Lercanidipine—Urticaria—Ifosfamide—germ cell cancer	0.000435	0.00157	CcSEcCtD
Lercanidipine—Abdominal pain—Ifosfamide—germ cell cancer	0.000433	0.00156	CcSEcCtD
Lercanidipine—Body temperature increased—Ifosfamide—germ cell cancer	0.000433	0.00156	CcSEcCtD
Lercanidipine—Pancytopenia—Methotrexate—germ cell cancer	0.000432	0.00156	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00043	0.00155	CcSEcCtD
Lercanidipine—Asthenia—Dactinomycin—germ cell cancer	0.000428	0.00155	CcSEcCtD
Lercanidipine—CYP3A5—endocrine gland—germ cell cancer	0.000426	0.00817	CbGeAlD
Lercanidipine—Neutropenia—Methotrexate—germ cell cancer	0.000426	0.00154	CcSEcCtD
Lercanidipine—Paraesthesia—Cisplatin—germ cell cancer	0.000424	0.00153	CcSEcCtD
Lercanidipine—Thrombocytopenia—Etoposide—germ cell cancer	0.000423	0.00153	CcSEcCtD
Lercanidipine—Tachycardia—Etoposide—germ cell cancer	0.000422	0.00152	CcSEcCtD
Lercanidipine—Dyspnoea—Cisplatin—germ cell cancer	0.000421	0.00152	CcSEcCtD
Lercanidipine—Skin disorder—Etoposide—germ cell cancer	0.00042	0.00152	CcSEcCtD
Lercanidipine—Erectile dysfunction—Methotrexate—germ cell cancer	0.000419	0.00152	CcSEcCtD
Lercanidipine—Hyperhidrosis—Etoposide—germ cell cancer	0.000418	0.00151	CcSEcCtD
Lercanidipine—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000416	0.0015	CcSEcCtD
Lercanidipine—Anorexia—Etoposide—germ cell cancer	0.000412	0.00149	CcSEcCtD
Lercanidipine—Decreased appetite—Cisplatin—germ cell cancer	0.00041	0.00148	CcSEcCtD
Lercanidipine—Diarrhoea—Dactinomycin—germ cell cancer	0.000409	0.00148	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000407	0.00147	CcSEcCtD
Lercanidipine—Vomiting—Bleomycin—germ cell cancer	0.000407	0.00147	CcSEcCtD
Lercanidipine—Hypotension—Etoposide—germ cell cancer	0.000404	0.00146	CcSEcCtD
Lercanidipine—Rash—Bleomycin—germ cell cancer	0.000404	0.00146	CcSEcCtD
Lercanidipine—Dermatitis—Bleomycin—germ cell cancer	0.000403	0.00146	CcSEcCtD
Lercanidipine—Hypersensitivity—Ifosfamide—germ cell cancer	0.000403	0.00146	CcSEcCtD
Lercanidipine—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000402	0.00145	CcSEcCtD
Lercanidipine—Renal failure—Methotrexate—germ cell cancer	0.000399	0.00144	CcSEcCtD
Lercanidipine—Stomatitis—Methotrexate—germ cell cancer	0.000396	0.00143	CcSEcCtD
Lercanidipine—Asthenia—Ifosfamide—germ cell cancer	0.000393	0.00142	CcSEcCtD
Lercanidipine—Feeling abnormal—Cisplatin—germ cell cancer	0.000389	0.0014	CcSEcCtD
Lercanidipine—Paraesthesia—Etoposide—germ cell cancer	0.000388	0.0014	CcSEcCtD
Lercanidipine—Pruritus—Ifosfamide—germ cell cancer	0.000387	0.0014	CcSEcCtD
Lercanidipine—Dyspnoea—Etoposide—germ cell cancer	0.000385	0.00139	CcSEcCtD
Lercanidipine—Somnolence—Etoposide—germ cell cancer	0.000384	0.00139	CcSEcCtD
Lercanidipine—Hepatobiliary disease—Methotrexate—germ cell cancer	0.000384	0.00139	CcSEcCtD
Lercanidipine—Nausea—Bleomycin—germ cell cancer	0.00038	0.00137	CcSEcCtD
Lercanidipine—Vomiting—Dactinomycin—germ cell cancer	0.00038	0.00137	CcSEcCtD
Lercanidipine—Agranulocytosis—Methotrexate—germ cell cancer	0.000379	0.00137	CcSEcCtD
Lercanidipine—Rash—Dactinomycin—germ cell cancer	0.000377	0.00136	CcSEcCtD
Lercanidipine—Decreased appetite—Etoposide—germ cell cancer	0.000376	0.00136	CcSEcCtD
Lercanidipine—Diarrhoea—Ifosfamide—germ cell cancer	0.000374	0.00135	CcSEcCtD
Lercanidipine—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000373	0.00135	CcSEcCtD
Lercanidipine—Body temperature increased—Cisplatin—germ cell cancer	0.000373	0.00135	CcSEcCtD
Lercanidipine—Fatigue—Etoposide—germ cell cancer	0.000373	0.00135	CcSEcCtD
Lercanidipine—Constipation—Etoposide—germ cell cancer	0.00037	0.00134	CcSEcCtD
Lercanidipine—Hepatitis—Methotrexate—germ cell cancer	0.000364	0.00132	CcSEcCtD
Lercanidipine—Dizziness—Ifosfamide—germ cell cancer	0.000362	0.00131	CcSEcCtD
Lercanidipine—Urinary tract disorder—Methotrexate—germ cell cancer	0.00036	0.0013	CcSEcCtD
Lercanidipine—Urethral disorder—Methotrexate—germ cell cancer	0.000357	0.00129	CcSEcCtD
Lercanidipine—Feeling abnormal—Etoposide—germ cell cancer	0.000356	0.00129	CcSEcCtD
Lercanidipine—Nausea—Dactinomycin—germ cell cancer	0.000355	0.00128	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Etoposide—germ cell cancer	0.000353	0.00128	CcSEcCtD
Lercanidipine—Vomiting—Ifosfamide—germ cell cancer	0.000348	0.00126	CcSEcCtD
Lercanidipine—Hypersensitivity—Cisplatin—germ cell cancer	0.000348	0.00126	CcSEcCtD
Lercanidipine—Rash—Ifosfamide—germ cell cancer	0.000345	0.00125	CcSEcCtD
Lercanidipine—Dermatitis—Ifosfamide—germ cell cancer	0.000345	0.00125	CcSEcCtD
Lercanidipine—Erythema multiforme—Methotrexate—germ cell cancer	0.000345	0.00125	CcSEcCtD
Lercanidipine—Urticaria—Etoposide—germ cell cancer	0.000343	0.00124	CcSEcCtD
Lercanidipine—Abdominal pain—Etoposide—germ cell cancer	0.000342	0.00123	CcSEcCtD
Lercanidipine—Body temperature increased—Etoposide—germ cell cancer	0.000342	0.00123	CcSEcCtD
Lercanidipine—Eye disorder—Methotrexate—germ cell cancer	0.000341	0.00123	CcSEcCtD
Lercanidipine—Tinnitus—Methotrexate—germ cell cancer	0.00034	0.00123	CcSEcCtD
Lercanidipine—Asthenia—Cisplatin—germ cell cancer	0.000338	0.00122	CcSEcCtD
Lercanidipine—Cardiac disorder—Methotrexate—germ cell cancer	0.000338	0.00122	CcSEcCtD
Lercanidipine—CYP2D6—female gonad—germ cell cancer	0.000338	0.00648	CbGeAlD
Lercanidipine—Angiopathy—Methotrexate—germ cell cancer	0.000331	0.00119	CcSEcCtD
Lercanidipine—Immune system disorder—Methotrexate—germ cell cancer	0.000329	0.00119	CcSEcCtD
Lercanidipine—Mediastinal disorder—Methotrexate—germ cell cancer	0.000328	0.00119	CcSEcCtD
Lercanidipine—Nausea—Ifosfamide—germ cell cancer	0.000325	0.00117	CcSEcCtD
Lercanidipine—Diarrhoea—Cisplatin—germ cell cancer	0.000323	0.00117	CcSEcCtD
Lercanidipine—Alopecia—Methotrexate—germ cell cancer	0.000322	0.00116	CcSEcCtD
Lercanidipine—CYP3A4—endocrine gland—germ cell cancer	0.00032	0.00613	CbGeAlD
Lercanidipine—Mental disorder—Methotrexate—germ cell cancer	0.000319	0.00115	CcSEcCtD
Lercanidipine—Hypersensitivity—Etoposide—germ cell cancer	0.000318	0.00115	CcSEcCtD
Lercanidipine—Malnutrition—Methotrexate—germ cell cancer	0.000317	0.00115	CcSEcCtD
Lercanidipine—Erythema—Methotrexate—germ cell cancer	0.000317	0.00115	CcSEcCtD
Lercanidipine—CYP2D6—endocrine gland—germ cell cancer	0.000314	0.00603	CbGeAlD
Lercanidipine—Dysgeusia—Methotrexate—germ cell cancer	0.000311	0.00112	CcSEcCtD
Lercanidipine—CYP2D6—head—germ cell cancer	0.00031	0.00595	CbGeAlD
Lercanidipine—Asthenia—Etoposide—germ cell cancer	0.00031	0.00112	CcSEcCtD
Lercanidipine—Pruritus—Etoposide—germ cell cancer	0.000306	0.0011	CcSEcCtD
Lercanidipine—Vomiting—Cisplatin—germ cell cancer	0.0003	0.00108	CcSEcCtD
Lercanidipine—CYP2D6—testis—germ cell cancer	0.0003	0.00575	CbGeAlD
Lercanidipine—Vision blurred—Methotrexate—germ cell cancer	0.000299	0.00108	CcSEcCtD
Lercanidipine—Rash—Cisplatin—germ cell cancer	0.000297	0.00107	CcSEcCtD
Lercanidipine—Dermatitis—Cisplatin—germ cell cancer	0.000297	0.00107	CcSEcCtD
Lercanidipine—Diarrhoea—Etoposide—germ cell cancer	0.000296	0.00107	CcSEcCtD
Lercanidipine—Ill-defined disorder—Methotrexate—germ cell cancer	0.000294	0.00106	CcSEcCtD
Lercanidipine—Anaemia—Methotrexate—germ cell cancer	0.000293	0.00106	CcSEcCtD
Lercanidipine—Malaise—Methotrexate—germ cell cancer	0.000286	0.00103	CcSEcCtD
Lercanidipine—Dizziness—Etoposide—germ cell cancer	0.000286	0.00103	CcSEcCtD
Lercanidipine—Vertigo—Methotrexate—germ cell cancer	0.000285	0.00103	CcSEcCtD
Lercanidipine—Nausea—Cisplatin—germ cell cancer	0.00028	0.00101	CcSEcCtD
Lercanidipine—CYP2D6—cerebellum—germ cell cancer	0.000277	0.00531	CbGeAlD
Lercanidipine—Cough—Methotrexate—germ cell cancer	0.000277	0.001	CcSEcCtD
Lercanidipine—Vomiting—Etoposide—germ cell cancer	0.000275	0.000993	CcSEcCtD
Lercanidipine—Rash—Etoposide—germ cell cancer	0.000273	0.000985	CcSEcCtD
Lercanidipine—Dermatitis—Etoposide—germ cell cancer	0.000272	0.000984	CcSEcCtD
Lercanidipine—Headache—Etoposide—germ cell cancer	0.000271	0.000978	CcSEcCtD
Lercanidipine—Chest pain—Methotrexate—germ cell cancer	0.00027	0.000976	CcSEcCtD
Lercanidipine—Arthralgia—Methotrexate—germ cell cancer	0.00027	0.000976	CcSEcCtD
Lercanidipine—Myalgia—Methotrexate—germ cell cancer	0.00027	0.000976	CcSEcCtD
Lercanidipine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000268	0.000969	CcSEcCtD
Lercanidipine—Discomfort—Methotrexate—germ cell cancer	0.000267	0.000964	CcSEcCtD
Lercanidipine—Confusional state—Methotrexate—germ cell cancer	0.000261	0.000943	CcSEcCtD
Lercanidipine—Nausea—Etoposide—germ cell cancer	0.000257	0.000928	CcSEcCtD
Lercanidipine—Nervous system disorder—Methotrexate—germ cell cancer	0.000254	0.000917	CcSEcCtD
Lercanidipine—Thrombocytopenia—Methotrexate—germ cell cancer	0.000253	0.000916	CcSEcCtD
Lercanidipine—Skin disorder—Methotrexate—germ cell cancer	0.000251	0.000909	CcSEcCtD
Lercanidipine—Hyperhidrosis—Methotrexate—germ cell cancer	0.00025	0.000904	CcSEcCtD
Lercanidipine—Anorexia—Methotrexate—germ cell cancer	0.000247	0.000892	CcSEcCtD
Lercanidipine—Hypotension—Methotrexate—germ cell cancer	0.000242	0.000874	CcSEcCtD
Lercanidipine—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000236	0.000852	CcSEcCtD
Lercanidipine—Insomnia—Methotrexate—germ cell cancer	0.000234	0.000846	CcSEcCtD
Lercanidipine—Paraesthesia—Methotrexate—germ cell cancer	0.000232	0.00084	CcSEcCtD
Lercanidipine—Dyspnoea—Methotrexate—germ cell cancer	0.000231	0.000834	CcSEcCtD
Lercanidipine—Somnolence—Methotrexate—germ cell cancer	0.00023	0.000832	CcSEcCtD
Lercanidipine—Dyspepsia—Methotrexate—germ cell cancer	0.000228	0.000823	CcSEcCtD
Lercanidipine—Decreased appetite—Methotrexate—germ cell cancer	0.000225	0.000813	CcSEcCtD
Lercanidipine—CYP2D6—brain—germ cell cancer	0.000225	0.00431	CbGeAlD
Lercanidipine—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000224	0.000808	CcSEcCtD
Lercanidipine—Fatigue—Methotrexate—germ cell cancer	0.000223	0.000807	CcSEcCtD
Lercanidipine—Feeling abnormal—Methotrexate—germ cell cancer	0.000213	0.000771	CcSEcCtD
Lercanidipine—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000212	0.000765	CcSEcCtD
Lercanidipine—Urticaria—Methotrexate—germ cell cancer	0.000206	0.000743	CcSEcCtD
Lercanidipine—Abdominal pain—Methotrexate—germ cell cancer	0.000205	0.00074	CcSEcCtD
Lercanidipine—Body temperature increased—Methotrexate—germ cell cancer	0.000205	0.00074	CcSEcCtD
Lercanidipine—Hypersensitivity—Methotrexate—germ cell cancer	0.000191	0.000689	CcSEcCtD
Lercanidipine—Asthenia—Methotrexate—germ cell cancer	0.000186	0.000671	CcSEcCtD
Lercanidipine—Pruritus—Methotrexate—germ cell cancer	0.000183	0.000662	CcSEcCtD
Lercanidipine—Diarrhoea—Methotrexate—germ cell cancer	0.000177	0.00064	CcSEcCtD
Lercanidipine—Dizziness—Methotrexate—germ cell cancer	0.000171	0.000619	CcSEcCtD
Lercanidipine—Vomiting—Methotrexate—germ cell cancer	0.000165	0.000595	CcSEcCtD
Lercanidipine—Rash—Methotrexate—germ cell cancer	0.000163	0.00059	CcSEcCtD
Lercanidipine—Dermatitis—Methotrexate—germ cell cancer	0.000163	0.000589	CcSEcCtD
Lercanidipine—Headache—Methotrexate—germ cell cancer	0.000162	0.000586	CcSEcCtD
Lercanidipine—Nausea—Methotrexate—germ cell cancer	0.000154	0.000556	CcSEcCtD
